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Abstract 
Background: Outer retinal tubulations (ORTs) are branching tubular structures located in the outer nuclear layer 
of the retina. The goal of this study is to determine the prevalence of ORTs observed in eyes with choroidal neovas-
cularization (CNV) undergoing treatment with anti-angiogenic intravitreous injection (IVI) with anti-VEGF (vascular 
endothelial growth factor) at the Ophthalmology Department of a tertiary hospital in São Paulo, Brazil.
Methods: This is a descriptive study based on medical charts and Spectral-domain Optical Coherence Tomography 
(Sd-OCT) scans of 142 patients (158 eyes) treated between 2012 and 2014 with IVI of anti-VEGF for CNV. The patients’ 
data was analysed according to age, gender, pathology, presence of ORTs, and best corrected visual acuity (BCVA). 
Patients with and without ORTs were compared according to the last BCVA obtained using Chi square corrected by 
the Yates factor.
Results: ORTs were found in a total of 40 out of 158 eyes (25.31 %) with CNV; in 33 out of 119 eyes (27.7 %) with 
neovascular age-related macular disease (AMD); in 5 out of 8 eyes (62.5 %) with neovascular angioid streaks; and in 2 
out of 12 eyes (16.67 %) with myopic neovascular membranes. Most patients with ORTs had BCVA worse than 20/200, 
significantly worse BCVA than patients without ORTs.
Conclusions: Recent studies have considered that the presence of ORTs is indicative of a photoreceptor degenera-
tion process and may represent a final stage of multiple retinal degenerative pathologies. The prevalence of ORTs in 
eyes with CNV has not been well described, especially when considering the Brazilian population treated in a public 
health care system. In our study, ORTs were observed in only three different pathologies: neovascular AMD, neovas-
cular angioid streaks and myopic neovascular membranes. The correct recognition of ORTs is fundamental for its 
differentiation from intraretinal cysts, for the latter is related to the activity of neovascular diseases, and usually guides 
anti-angiogenic therapy. We conclude that ORTs have a high prevalence in the population studied, and their correct 
identification presents relevant therapeutic implications.
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Background
The advances in images obtained with spectral-domain 
optical coherence tomography (SD-OCT) allowed fur-
ther analysis of retinal and choroidal structures [1].
In 2009, Zweifel et  al. [1] first described the “outer 
retinal tubulation” (ORT), branching tubular structures 
located in the outer nuclear layer of the retina, which 
appeared as round or ovoid hyporeflective spaces with a 
hyperreflective border.
The ORTs were initially observed in eyes with choroidal 
neovascularization (CNV) secondary to age-related mac-
ular degeneration (AMD). More recently, the same alter-
ations were described in other conditions such as retinal 
and choroidal dystrophies, multifocal choroiditis, central 
serous choroidopathy, acute zonal occult outer retinopa-
thy and dry AMD with geographic atrophy [1–9].
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The importance of ORTs was highlighted by the post 
hoc analysis of the multicentric comparison of age-
related macular degeneration treatments trial (CATT) 
study [10]. Considering the current definition of ORTs, 
after a 2-year follow-up of patients with AMD and CNV 
under anti-angiogenic treatment, this OCT finding was 
present in 17,4 % of the cases and was related to a worse 
final visual acuity [10].
The diferentiation of ORTs from intraretinal cysts 
presents extremely relevant therapeutic implications 
as the latter are indicative of exsudative activity in dis-
eases such as age-related macular degeneration, diabetic 
macular edema and vascular occlusions. Specifically for 
CNV related to AMD, the improvement of visual acuity 
achieved with monthly intravitreal anti-angiogenic treat-
ment for 24 consecutive months led to the approval of 
this type of treatment by the FDA [11, 12]. Later, studies 
such as PRONTO [13] and CATT [10] showed that simi-
lar visual acuity could be obtained with fewer intravitreal 
injections, guided by disease activity parameters such as 
intraretinal or subretinal fluid detected on OCT.
The aim of this study is to determine the prevalence of 
ORTs in eyes with CNV undergoing treatment with anti-
angiogenic intravitreous injection (IVI) with anti-VEGF 
(vascular endothelial growth factor) at the Ophthalmol-
ogy Department of a tertiary hospital in São Paulo, Brazil.
Methods
This is a descriptive study based on medical charts of 
patients enrolled at the Ophthalmology Department 
of the“Hospital das Clinicas”, at the University of São 
Paulo—São Paulo, Brazil. The SD-OCT scans of the last 
recorded visit of 142 patients (158 eyes) treated between 
2012 and 2014 with IVIs of anti-VEGF for CNV were 
evaluated. All of these patients were treated with IVIs of 
bevacizumab, in a pro re nata (PRN) regimen. The images 
were obtained by the Heidelberg Spectralis (Spectralis 
Engineering, Heidelberg, Germany) SD-OCT.
ORTs were defined as round or ovoid structures, 
always with hyperreflective borders, located at the outer 
nuclear layer (ONL) (Fig. 1), and were differentiated from 
intraretinal cysts, as the latter are observed at the inner 
retinal layers and present hyporeflective borders (Figs. 2, 
3 and 4).
Image analysis was performed by two retinal special-
ists. When there was no agreement between examiners, 
the image was considered inconclusive and therefore not 
to be an ORT.
The data of patients with CNV was analysed accord-
ing to age, gender, type of involvement (uni- or bilateral), 
pathology, presence of ORTs, and best corrected visual 
acuity (BCVA, early treatment diabetic retinopathy study 
score) at the final visit (better than 20/40; from 20/40 
to 20/200; worse than 20/200). Patients with and with-
out ORTs were compared according to the last BCVA 
obtained using Chi square corrected by the Yates factor. 
P  <  0.01 was considered as statistically significant. The 
prevalence of ORTs was estimated by dividing the num-
ber of patients with ORTs by the total number of patients 
examined during the study period.
Results
A total of 142 patients (158 eyes with CNV) were 
included in the study. Seventy-nine patients (55.64  %) 
were women and 59 (44.36 %) were men. The mean age 
was 58 (24–94 years).
ORTs were present in only three different pathologies 
with CNV: 33 out of 119 eyes (27.7 %) with neovascular 
AMD; 5 out of 8 eyes (62.5 %) with neovascular angioid 
streaks; and 2 out of 12 eyes (16.67 %) with myopic CNV. 
A total of 40 out of 158 eyes (25.31  %) with CNV pre-
sented ORTs.
Other conditions also subjected to IVIs of anti-VEGF 
for CNV (serpiginous chorioretinopathy, central serous 
chorioretinopathy, choroidal hemangioma, retinal arte-
rial macroaneurysm, familial drusen, Vogt-Koyanagi-
Harada syndrome) did not demonstrate ORTs. (Table 1).
The majority of patients with ORTs had a BCVA worse 
than 20/200 (57.7 % in neovascular AMD, 60 % in angioid 
streaks and 50  % in myopic CNV), while those rates 
were 51.1, 66.7 and 40 %, respectively, for patients with-
out ORTs. (Table  2) Patients with ORTs had a statisti-
cally worse BCVA when compared with patients without 
ORTs (Chi Square equals to 119.8, P < 0.01).
Discussion
ORTs were first described by Zweifel et  al. [1] in 2009, 
based on their appearance on SD-OCT scans as round 
hyporeflective spaces with hyperreflective borders, 
located in the retinal outer nuclear layer. Those structural 
changes were only systematically described after the pop-
ularization of SD-OCT, as time-domain optical coher-
ence tomography (Stratus OCT, Zeiss, Germany) did 
not have enough resolution to differentiate them from 
intraretinal cysts [1].
Initially, ORTs were characterized as interconnect-
ing tubules with degenerated photoreceptors and Mül-
ler cells [14]. Recent clinicopathological findings showed 
that the ORT reflective border represents the mitochon-
dria within degenerated inner segments (IS) translocated 
internally to the external limiting membrane (ELM), 
without the presence of outer segments [15, 16].
Recent studies have considered that the presence of 
ORTs is indicative of a photoreceptor degeneration pro-
cess and may represent the final stage of multiple advanced 
retinal diseases, such as: neovascular AMD, polypoidal 
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choroidal vasculopathy (and other causes of CNV); retinal 
or choroidal dystrophies (gyrate atrophy, choroideremia, 
cone dystrophy, Bietti crystalline dystrophy, Stargardt 
disease, pattern dystrophy); central serous choroidopathy 
and acute zonal occult outer retinopathy [1–9, 17, 18]. The 
prevalence of ORTs in eyes with CNV has not been well 
described, especially when considering the Brazilian popu-
lation treated in a public health care system.
In our study, from the 158 eyes with CNV that received 
anti-VEGF therapy, the ORTs were only found in three 
distinct pathologies: neovascular AMD, angioid streaks 
and myopic CNV, with a high prevalence in the first two 
conditions (27.7 and 16.67  %, respectively). Such data 
suggests that those conditions may produce more dam-
age to the photoreceptors that, in an attempt to survive in 
a hostile environment, tend to form the tubules.
Fig. 1 Outer retinal tubulation (ORT) in patients with exsudative AMD treated with IVI anti-VEGF. All images were obtained with the Heidelberg 
SD-OCT. a Annular lesions with hyporeflective lumens and hyperreflective borders at the outer nuclear layer (ONL) b ORTs are restricted to the ONL 
of the retina. c–d. Different shapes of ORTs
Fig. 2 Differentiation between ORT and intraretinal cysts. a–b. Next to the circular ORT lesion (with hyperreflective borders) there are multiple 
intraretinal cysts (with hyporeflective borders) in the innermost layers of the retina
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Previous reports have described the high prevalence of 
ORTs in neovascular AMD (8.2–40 %) [1, 6, 17, 19]. The 
high proportion of patients with neovascular AMD and 
ORTs in our study (27.7 %) is similar to the prevalence of 
ORTs observed in tertiary care centers in Switzerland and 
France (30 and 38.1 %, respectively) [19, 20], but is higher 
than the value observed at the CATT study (17.4 %) [10]. 
The lower prevalence at the CATT trial may be explained 
Fig. 3 Outer retinal tubulation (ORT) in patient with disciform scar. a Infrared image shows a macular lesion. b An annular ORT can be observed 
internally to the disciform scar, in the ONL (yellow asterisk); and micro intraretinal cysts are found in the inner nuclear layer (white asterisk)
Fig. 4 Differentiation between ORT and intraretinal cysts in patient with disciform scar. a Infrared image shows a macular lesion. b Two intraretinal 
cysts with hyporeflective borders and an ORT with circular hyperreflective border very close to areas of neovascular fibrosis
Table 1 Demographics and diagnosis of patients with choroidal neovascularization
Disease n (%) patients Gender Age Eyes ORTs
F M
Neovascular AMD 105 (73.9 %) 53 (67.3 %) 52 (88.1 %) 76.3 (50–97) 119 (75.4 %) 33 (27.7 %)
Neovascular angioid streaks 7 (4.9 %) 5 (6.3 %) 2 (3.4 %) 60.1 (41–79) 8 (5.0 %) 5 (62.5 %)
VKH syndrome 10 (7 %) 9 (11,4 %) 0 42.5 (25–67) 11 (7.2 %) 0
Myopic CNV 12 (8.4 %) 9 (11.4 %) 0 56.8 (24–94) 12 (7.6 %) 2 (16.67 %)
Polypoidal choroidal vasculopathy 1 (0.7 %) 1 (1.2 %) 0 78 1 (0.6 %) 0
Serpiginous chorioretinopathy 1 (0.7 %) 1 (1.2 %) 0 41 1 (0.6 %) 0
Arterial macroaneurism 1 (0.7 %) 0 1 (1.7 %) 63 1 (0.6 %) 0
Choroidal hemangioma 1 (0.7 %) 0 1 (1.7 %) 51 1 (0.6 %) 0
Central serous chorioretinopathy 3 (2.1 %) 0 3 (5.1 %) 66 (57–77) 3 (1.8 %) 0
Familial drusen 1 (0.7 %) 1 (1.2 %) 0 46 1 (0.6 %) 0
Total 142 (100 %) 79 (100 %) 59 (100 %) 58 158 (100 %) 40
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by its rigid inclusion criteria that excluded some chronic 
partially fibrotic cases, differing from a real life scenario 
such as ours.
The relationship between ORTs and CNV activity and 
its response to anti-VEGF therapy is still unknown. How-
ever, in our cases, eyes with ORTs had significantly worse 
visual acuity than those without ORTs, possibly because 
of the association between ORTs and photoreceptor 
degeneration [10, 17]. Therefore, ORTs may predict dis-
ease severity, despite the possibility of having ORTs and 
BCVA better than 20/40. In some studies, the prevalence 
of ORT in neovascular AMD and angioid streaks was 
lower in eyes with better VA (>20/40), suggesting that 
disease severity may be a trigger to ORT formation [1, 10, 
19].
The prevalence of ORTs increases progressively with 
follow-up despite treatment with anti-VEGF. Darien et al. 
observed an increase from 2.5 % at baseline to 40 % after 
a 4-year period of treatment with ranibizumab [19]. A 
subtle increase was also observed in a post hoc evalua-
tion of the CATT study, when comparing week 52 and 
week 104. The ORT prevalence increased from 10.1 to 
17.4  %, respectively [10]. Interestingly, the regimen of 
treatments (PRN or monthly treatments) did not alter the 
prevalence of ORTs.
Recently, new studies involving SD-OCT angiography 
allow the clinician to visualize CNV noninvasively and 
may provide a method for identifying and guiding treat-
ment of CNV [21]. It would be interesting if further anal-
ysis using this new technology was performed in patients 
with ORT.
Conclusions
In conclusion, the prevalence of ORTs in a population 
with CNV treated with anti-VEGF therapy at a tertiary 
public health center in Brazil is similar to that found in 
European studies [19, 20]. Its correct recognition is fun-
damental for differentiation from intraretinal cysts, fre-
quently an indicative of active neovascular disease, and 
therefore a guide to anti-angiogenic therapy in PRN regi-
mens. Despite its presence in degenerative processes, the 
existence of ORTs must not be considered a sign of exsu-
dative disease, but rather a degenerative structural sign. 
Patients with ORTs usually present a worse BCVA when 
compared to patients without this finding, but a good vis-
ual outcome may be possible even in the presence of this 
alteration.
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